Contract Service Provider - Biotuesdays · 2011-01-13 · •immunotechnology •Biochemistry o ISO...
16
OEM Manufacturing OEM Manufacturing Contract Service Provider Contract Service Provider
Transcript of Contract Service Provider - Biotuesdays · 2011-01-13 · •immunotechnology •Biochemistry o ISO...
OEM Manufacturing OEM Manufacturing
Contract Service ProviderContract Service Provider
Indicia ‘at a glance’
233, avenue de la Californie – 69600 Oullins - FR
ZA la Parlière – 69610 St Genis l’Argentière - FR
Indicia ‘at a glance’
333, avenue de la Californie – 69600 Oullins - FR
ZA la Parlière – 69610 St Genis l’Argentière - FR
Turnover
2008 – 2012
CREATION
ORGANIC
GROWTH
2003-2007
EXTERNAL
GROWTH
• Axcell Biotechnologies.
• Other opportunities
1998-2002
1998
2007
2010 (4.4 M€)
2003
Facilities
R&D & Bioanalysis
o Laboratory surface: 250 sq.m
o 15 employees
o Team of scientists specialized in
• immunotechnology
• Biochemistry
o ISO 9001:2008 & ISO 13485
Manufacturing
o Building surface: 3000 sq.m
o 400 sq.m. of cleanroom
o Biosafety level 2 lab.
o 35 employees
o ISO 9001/ISO 13485
o Meet GMP guidelines
433, avenue de la Californie – 69600 Oullins - FR
ZA la Parlière – 69610 St Genis l’Argentière - FR
Contract Service portfolio
533, avenue de la Californie – 69600 Oullins - FR
ZA la Parlière – 69610 St Genis l’Argentière - FR
Contract Service portfolio
633, avenue de la Californie – 69600 Oullins - FR
ZA la Parlière – 69610 St Genis l’Argentière - FR
Scope of expertise
733, avenue de la Californie – 69600 Oullins - FR
ZA la Parlière – 69610 St Genis l’Argentière - FR
Contract Service portfolio
8
Biomarker
Identification
Immunoassays
(Multiplex)
Sample testing
ERENNA®
(Singulex)
ANTIBODIES &
RELATED SERVICES
CROHN DISEASE
(FUI)
NEURODEGENERATIVE
DISEASES
(OSEO)
IMMUNOGENICITY RISK
ASSESSMENT
CYTOKINE
EXPRESSION
BIOMARKER
QUANTIFICATION
…
CARDIOVASCULAR
DISEASES
(ISI)
933, avenue de la Californie – 69600 Oullins - FR
ZA la Parlière – 69610 St Genis l’Argentière - FR
Indicia Production
1033, avenue de la Californie – 69600 Oullins - FR
ZA la Parlière – 69610 St Genis l’Argentière - FR
� PHARMAFormulation, production and filling of sterile media and raw pharmaceutical products (API)
� INDUSTRYProduction of ready-to-use microbiological media
� DM/DIVMedical devices (Sterile & liquid)
Perspectives 2011 - 2016
11
IVD Products
(licensing out)Biomarker
Identification
Assay Development
Sample testing
Perspectives 2011 - 2016
Partnering Acquisition Training R&D Financial
MAIN CHALLENGES
1 – Technologies (Assay Development & Sample Testing)
2 – Reglementary Environment
4 – IP
12
Perspectives 2011 - 2016
1 – Fund raising (July 2011)
2 – Acquisition of an animal house (April 2011)
3 - Indicia Production: investment of 800 k€ - GMP compliance(Jan – July 2011 – Supported by Conseil Général du Rhône)
4 - IRT
13
Early 2011
Perspectives 2011 - 2016
Indicia joins the IRT project supported by
The Lyon Biopôle & Institut Pasteur
Characterization of the patient’s immune response
Bioanalytical Plate-form
SME : Indicia – ImmunID – Platine – Imaxio – Biomnis …
14
15
Stéphane Legastelois - President & CEO
Elodie Panier – General Manager – Programme coordinator
Christophe Onillon – Export Sale Manager
Marie-Pierre Varenne – Head of Production
33, avenue de la Californie – 69600 Oullins – FR
Tel: +33 4 72 39 14 92
www.indicia.fr
Contact us
33, avenue de la Californie – 69600 Oullins - FR
ZA la Parlière – 69610 St Genis l’Argentière - FR
1633, avenue de la Californie – 69600 Oullins - FR
ZA la Parlière – 69610 St Genis l’Argentière - FR
Thank you for your attention
INDICIA wishes you a
Happy New Year 2011
